Group One Trading’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,475,200
| Closed | -$43.7M | – | 8258 |
|
|
2023
Q4 | $43.7M | Buy |
1,475,200
+1,269,300
| +616% | +$25.3M | 0.12% | 116 |
|
|
2023
Q3 | $3.27M | Sell |
205,900
-159,900
| -44% | -$2.66M | 0.01% | 1245 |
|
|
2023
Q2 | $6.9M | Sell |
365,800
-217,300
| -37% | -$2.57M | 0.02% | 740 |
|
|
2023
Q1 | $2.24M | Buy |
583,100
+486,200
| +502% | +$2.07M | 0.01% | 1433 |
|
|
2022
Q4 | $481K | Sell |
96,900
-24,600
| -20% | -$133K | ﹤0.01% | 3080 |
|
|
2022
Q3 | $581K | Buy |
121,500
+33,900
| +39% | +$179K | ﹤0.01% | 3095 |
|
|
2022
Q2 | $394K | Sell |
87,600
-25,600
| -23% | -$111K | ﹤0.01% | 3649 |
|
|
2022
Q1 | $539K | Sell |
113,200
-83,900
| -43% | -$465K | ﹤0.01% | 3728 |
|
|
2021
Q4 | $1.46M | Buy |
197,100
+101,000
| +105% | +$628K | ﹤0.01% | 2945 |
|
|
2021
Q3 | $545K | Sell |
96,100
-139,600
| -59% | -$807K | ﹤0.01% | 4098 |
|
|
2021
Q2 | $1.55M | Buy |
235,700
+73,000
| +45% | +$509K | ﹤0.01% | 2906 |
|
|
2021
Q1 | $1.32M | Buy |
162,700
+112,600
| +225% | +$919K | ﹤0.01% | 2917 |
|
|
2020
Q4 | $323K | Buy |
50,100
+36,900
| +280% | +$215K | ﹤0.01% | 3673 |
|
|
2020
Q3 | $48K | Sell |
13,200
-28,900
| -69% | -$117K | ﹤0.01% | 4681 |
|
|
2020
Q2 | $194K | Sell |
42,100
-6,700
| -14% | -$28.5K | ﹤0.01% | 3404 |
|
|
2020
Q1 | $166K | Sell |
48,800
-260,100
| -84% | -$1.14M | ﹤0.01% | 2900 |
|
|
2019
Q4 | $1.58M | Sell |
308,900
-58,500
| -16% | -$199K | 0.01% | 1484 |
|
|
2019
Q3 | $889K | Buy |
367,400
+318,500
| +651% | +$846K | 0.01% | 1833 |
|
|
2019
Q2 | $106K | Sell |
48,900
-22,500
| -32% | -$53.2K | ﹤0.01% | 3307 |
|
|
2019
Q1 | $193K | Buy |
71,400
+500
| +0.7% | +$2.17K | ﹤0.01% | 2736 |
|
|
2018
Q4 | $340K | Buy |
70,900
+43,400
| +158% | +$263K | ﹤0.01% | 2269 |
|
|
2018
Q3 | $260K | Sell |
27,500
-79,400
| -74% | -$763K | ﹤0.01% | 2820 |
|
|
2018
Q2 | $1.04M | Sell |
106,900
-111,700
| -51% | -$1.18M | 0.01% | 1691 |
|
|
2018
Q1 | $2.3M | Buy |
218,600
+164,500
| +304% | +$1.62M | 0.02% | 916 |
|
|
2017
Q4 | $347K | Sell |
54,100
-36,900
| -41% | -$228K | ﹤0.01% | 2547 |
|
|
2017
Q3 | $696K | Buy |
91,000
+53,600
| +143% | +$356K | 0.01% | 1822 |
|
|
2017
Q2 | $266K | Sell |
37,400
-1,400
| -4% | -$6.41K | ﹤0.01% | 2438 |
|
|
2017
Q1 | $150K | Sell |
38,800
-127,600
| -77% | -$372K | ﹤0.01% | 2721 |
|
|
2016
Q4 | $339K | Buy |
166,400
+104,200
| +168% | +$209K | ﹤0.01% | 2041 |
|
|
2016
Q3 | $167K | Buy |
62,200
+61,700
| +12,340% | +$179K | ﹤0.01% | 2603 |
|
|
2016
Q2 | $2K | Sell |
500
-14,300
| -97% | -$89.7K | ﹤0.01% | 4451 |
|
|
2016
Q1 | $126K | Buy |
14,800
+3,100
| +26% | +$26.2K | ﹤0.01% | 2668 |
|
|
2015
Q4 | $159K | Sell |
11,700
-16,700
| -59% | -$206K | ﹤0.01% | 2667 |
|
|
2015
Q3 | $273K | Sell |
28,400
-35,200
| -55% | -$515K | ﹤0.01% | 2268 |
|
|
2015
Q2 | $915K | Buy |
63,600
+23,600
| +59% | +$259K | 0.01% | 1279 |
|
|
2015
Q1 | $358K | Buy |
40,000
+200
| +0.5% | +$1.45K | 0.01% | 1884 |
|
|
2014
Q4 | $243K | Buy |
39,800
+18,500
| +87% | +$169K | ﹤0.01% | 2142 |
|
|
2014
Q3 | $226K | Buy |
21,300
+12,000
| +129% | +$136K | ﹤0.01% | 2285 |
|
|
2014
Q2 | $110K | Sell |
9,300
-5,100
| -35% | -$64K | ﹤0.01% | 2892 |
|
|
2014
Q1 | $215K | Sell |
14,400
-21,600
| -60% | -$341K | ﹤0.01% | 2383 |
|
|
2013
Q4 | $528K | Buy |
36,000
+21,000
| +140% | +$323K | 0.01% | 1623 |
|
|
2013
Q3 | $255K | Sell |
15,000
-8,800
| -37% | -$155K | ﹤0.01% | 2169 |
|
|
2013
Q2 | $395K | Buy |
+23,800
| New | +$386K | 0.01% | 1543 |
|
Other funds holding IMGN
Group One Trading's IMGN Position: Q4 2023 in Review
Group One Trading sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 238,327 shares — an estimated $4.75M sold.
Group One Trading first reported a position in IMGN in Q2 2013 and held it in 33 quarters. The position peaked at $3.78M in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.
- Group One Trading reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
- Group One Trading sold 238,327 Immunogen Inc shares in Q4 2023, an estimated $4.75M.
- Group One Trading first reported a position in Immunogen Inc in Q2 2013 and held it in 33 quarters.
- Group One Trading's Immunogen Inc position peaked at $3.78M in Q3 2023.
- 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.
Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.